Navigation Links
Mirixa's Healthcare Success in Software-as-a-Service and IT/Business Integration Recognized in Gartner Publication
Date:3/20/2008

RESTON, Va., March 20 /PRNewswire/ -- Mirixa Corporation announced today that its strategic use of Information Technology was recently highlighted by Gartner's EXP CIO Signature, a high-level industry publication targeted exclusively to CIO of major corporations.

The October 2007 issue of Gartner EXP CIO Signature, "Getting the Right IT: Using Business Models," written by Richard Hunter, described how CEOs can ensure they are getting the right IT for their companies and examined working business models to give industry leaders new insights. Mirixa was featured along with other industry leaders including Weyerhaeuser, Siemens AG, and ABB.

"The perennial challenge for any CIO is how to align IT with the business," said Carberry. "What Mirixa has been able to do is develop a user-friendly IT platform to reach a critical sector of the healthcare industry -- pharmacists -- and provide them with services that generate a new revenue stream and work toward improving patient health, thereby enabling the business model for our company."

Mirixa operates by providing technology and supportive services to pharmacies, pharmacists and their patients through its Software-As-A-Service (SaaS) web-based solution, MirixaPro(SM). Mirixa's innovative clinical solutions suite enables pharmacists to easily deliver patient care services in conjunction with healthcare providers to achieve improved patient outcomes, lower operating costs, and to produce patient care revenues in addition to pharmacies' traditional dispensing and merchandising business.

"Everything we do is enabled by our IT platform," said Carberry. "We may be new to the industry, but this platform has successfully scaled with our business and produced positive impact on the ability of pharmacists to deliver clinical patient care services that improve safety, quality of care, and ultimately control healthcare costs."

About Mirixa

Mirixa Corporation is a leader in targeted patien
'/>"/>

SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
2. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
3. Flagship Global Health and China HealthCare Holdings Form Strategic Alliance
4. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
5. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
6. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
7. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
8. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
9. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
10. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
11. Unions Successful in Targeting Healthcare Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...g to two studies presented today, a nonsurgical tr... diseased thoracic aorta// offered patients less r...ortality rates when compared to surgery. During su... paraplegia because the thoracic aorta is clamped,...
... of existing research confirms that health-care wo...eatment if they are exposed// to HIV on the job. ... research into so-called occupational postexposure... what should be done when health-care workers are ...
... Food and Drug Administration (FDA) and the Center...inding consumers of the dangers of drinking milk t... Raw milk potentially contains a wide variety of ...:H7, Listeria, Campylobacter and Brucella – that m...
...n, the compound that gives red pepper its heat, co...boratory study.// If the results can be replicate...ngthening of capsaicin in the weight management su... by Euromonitor International to be worth US$0.93b...
Other Medicine News:Health News:Nonsurgical Thoracic Aorta Repair Has Much Less Risk of Paralysis Than Surgery 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 3Health News:FDA and CDC Remind Consumers of the Dangers of Drinking Raw Milk 2Health News:Chilli Extract may Stop Fat Cell Growth 2
(Date:10/6/2008)...6 Weeks of Radiation Therapy -, Event: Watch Singl...sday, October 22, 2008, 3 - 4 p.m. by visiting ...Va., Oct. 6 / Questions raced through...st cancer in May. Would she have the,tumor removed...otherapy?, , To view the Multimedia News Release...
(Date:10/6/2008)...mpany,s Bioabsorbable Stent - Also,Slated for Pres...ire/ -- Data from multiple clinical trials of,the ...us Bio-engineered R,stent, will be presented next ...ics symposium, TCT 2008, in Washington, D.C., Rob...al Center in,Amsterdam will provide a Genous clini...
(Date:10/5/2008)...urnal of Medicine reaffirm,well-established effica...iHaler(R), RIDGEFIELD, Conn., and NEW YORK, Oct. ...ding Potential Long-term Impacts on Function with,...er(R) (tiotropium bromide,inhalation powder), sust...ars as measured by FEV(1) (p<0.001) versus placebo...
(Date:10/3/2008)...rstCall/ -- Amsterdam Molecular,Therapeutics (Euro...erapy,announced today that it intends to incorpor...on Application (MAA) for Glybera(R) for Lipoprotei...ng and potentially lethal,disease., The data obta...,patients in total) demonstrate that Glybera(R) is...
Breaking Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 1Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 1UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 3AVMA Collections Highlights Disaster Preparedness 23244 1AVMA Collections Highlights Disaster Preparedness 23244 2GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 1GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 2
...gulatory News-Ipsen,(Paris:IPN) announced today th... study for its investigational 4-month formulation...nable blood levels,of triptorelin for a duration o...ecided not to perform the second,administration as...been observed throughout the trial. At the end of ...
...re/ -- GlaxoSmithKline,plc announced results from ...nvestigational non-peptide oral platelet growth,fa... this study,showed that PROMACTA at 50-75mg once d...ase in platelet counts and also,reduced bleeding i...topenic purpura (ITP). These patients had previous...
Other Medicine Technology:Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 2Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: